ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
  • Abstract Number: 556
    Identification and Validation of S100 Salivary Proteins As Putative Biomarkers for Different  Subsets of Primary Sjögren’s Syndrome Patients
  • Abstract Number: 180
    Identification of a Functional Susceptible Variant in Distal Enhancer of Mir-146a By CRISPR-Cas9
  • Abstract Number: 1668
    Identification of a Serum Measure of Lupus Nephritis Activity That Detects Molecular Pathways and Mechanisms Implicated in Renal Damage
  • Abstract Number: 1722
    Identification of a Sub-Population of Autoantibodies Targeting BICD2 Cross-Reacting with CENP-a Derived Peptides in Patients with Systemic Sclerosis
  • Abstract Number: 758
    Identification of Biomarkers Predictive of Pulmonary Arterial Hypertension in Systemic Sclerosis
  • Abstract Number: 1010
    Identification of Circulating Biomarkers of Disease Activity and Organ Involvement in ANCA-Associated Vasculitis By Targeted Proteomics
  • Abstract Number: 2602
    Identification of Clinical and Serological Predictive Factors of Response to Rituximab Treatment in Systemic LUPUS Erythematosus (SLE) Patients
  • Abstract Number: 858
    Identification of Clinically Relevant Pain Profiles in Individuals with Active RA
  • Abstract Number: 181
    Identification of Disease-Susceptible Lncrna Contributed to Abnormal Activation of Type I Interferon Pathway in Systemic Lupus Erythematosus
  • Abstract Number: 674
    Identification of IRAK4-Dependent Gene Signature As a Biomarker Candidate for IRAK4 Small-Molecule Inhibitor in Systemic Lupus Erythematosus
  • Abstract Number: 1334
    Identification of Key Regulators for Resolution of Chronic Inflammatory Arthritis through a Systems Approach
  • Abstract Number: 984
    Identification of Key Screening Characteristics for Systemic Lupus Erythematosus Natural History
  • Abstract Number: 1659
    Identification of Long Noncoding RNA RP11-2B6.2 As a Positive Regulator through Type I Interferon Pathway in Lupus Nephritis
  • Abstract Number: 2125
    Identification of Long-Term Prognostic Factors for Relapse or Exacerbation in Patients with Pulmonary Sarcoidosis: A Single Center Long-Term Observational Cohort Study
  • Abstract Number: 2134
    Identification of Multiple Cancer Associated Myositis Specific Antibodies in Idiopathic Inflammatory Myopathies: A Large Longitudinal Cohort Study
  • Abstract Number: 950
    Identification of Naturally Processed Immunodominant Topoisomerase I Epitopes in Patients with Systemic Sclerosis
  • Abstract Number: 168
    Identification of Novel Susceptibility Loci in a Large UK Cohort of Juvenile Idiopathic Arthritis (JIA) Cases
  • Abstract Number: 2270
    Identification of Optimal Subcutaneous Doses of Tocilizumab in Children with Polyarticular-Course Juvenile Idiopathic Arthritis
  • Abstract Number: 2976
    Identification of Systemic Lupus Erythematosus Causal Risk Variant Candidates Spanning the UBE2L3 Haplotype
  • Abstract Number: 2057
    Identification of Urate Deposits in Patients with Asymptomatic Hyperuricemia Using a Dual-Energy CT Scan
  • Abstract Number: 2
    Identifying “Second Hit” Risk Factor(s) Associated with Thrombosis and Pregnancy Morbidity in Ethnically Diverse Antiphospholipid Antibodies Positive Patients
  • Abstract Number: 983
    Identifying Exposures to Chemicals in Patients with SLE – a Non-Targeted Exposome Approach Reveals Enrichment for Phthalates
  • Abstract Number: 1871
    Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype
  • Abstract Number: 859
    Identifying Pain Susceptibility Phenotypes in Those Free of Knee Pain with or at Risk for Knee Osteoarthritis and Their Relation to Developing Knee Pain
  • Abstract Number: 2946
    Identifying Rapid Structural Disease Progression in Knee Osteoarthritis
  • Abstract Number: 1854
    Identifying Vulnerable Patient Populations Based on Age and Physical Function on Clinical Outcomes Following Total Knee Arthroplasty
  • Abstract Number: 1857
    If Mobile Advertising Is the Future, the Future Is Now:  Productivity of Digital Ads By Terminology and Delivery Device.
  • Abstract Number: 2882
    IgG Galactosylation Status Combined with MYOM2 SNP Precisely Predicts Anti-TNF Response in Ankylosing Spondylitis
  • Abstract Number: 74
    IL-17 Blockade Attenuates Osteoblastic Activity and Differentiation in Ankylosing Spondylitis
  • Abstract Number: 659
    IL-17 Producing T Cells and Its Dichotomy: A Mixed Response of the Innate and Acquired Immune System in Psoriatic Arthritis
  • Abstract Number: 975
    IL-17A Induced Autophagy That the Proliferation of Rheumatoid Arthritis Fibroblast-like Synoviocytes through Down-Regulation of PI3K/AKT/mTOR Signaling Pathway
  • Abstract Number: 1896
    IL-18 As a Diagnostic Biomarker, Differentiating Systemic JIA from Acute Leukaemia, Severe Bacterial Infections and Other Auto-Immune Disorders
  • Abstract Number: 2698
    IL-21-mTOR Axis Blocks the Differentiation and Function of SLE Tregs Via Suppression of Autophagy
  • Abstract Number: 1576
    IL-23 Promotes Fecal Microbiota Dysbiosis Associated with Susceptibility to Spondyloarthritis and Ileitis in ZAP-70 Mutant SKG Mice
  • Abstract Number: 34
    IL-23 Regulates Development of Spontaneous Germinal Centers and Pathogenic Autoantibody Production in BXD2 Mice
  • Abstract Number: 78
    IL-37 Is Associated with Increased Atherogenesis in Patients with Rheumatoid Arthritis
  • Abstract Number: 973
    IL-6 and TNF-a Cooperate to Modulate the Cell Cycle of RA-Fibroblast-like Synoviocytes Via Cyclin Dependent Kinase Inhibitors
  • Abstract Number: 1730
    IL-6 Mediates Activation of Macrophages in Patients with Systemic Sclerosis
  • Abstract Number: 1795
    IL-7 in Primary Sjogren Syndrome (pSS) Is Secreted By Salivary Gland Epithelial Cells after IFN Stimulation and Is Associated with B-Cell Activation
  • Abstract Number: 864
    IL-9-Producing Innate Lymphoid Cells – Keyplayers That Orchestrate Resolution of Chronic Inflammation in Arthritis
  • Abstract Number: 940
    IL1RN Variation Is Associated with Systemic Juvenile Idiopathic Arthritis and Predicts Non-Response to Anakinra Treatment
  • Abstract Number: 2571
    IL23 Deficiency Alters Thymic Selection in Lupus Prone Mice
  • Abstract Number: 594
    Imaging Biomarkers in Crohn’s Associated Axial Spondyloarthritis
  • Abstract Number: 259
    Imaging for Diagnosis, Monitoring and Outcome Prediction of Large Vessel Vasculitis: A Systematic Review of the Literature and Meta-Analysis Informing the EULAR Recommendations
  • Abstract Number: 850
    Immune Checkpoint Inhibitors and Inflammatory Myopathies: Data from the US Food and Drug Administration Adverse Event Reporting System
  • Abstract Number: 2641
    Immune Complex-Driven Neutrophil Activation in Systemic Lupus Erythematosus – Novel Biomarkers of Disease Activity and Severity
  • Abstract Number: 566
    Immune Response to Seasonal Flu Vaccination in Patients with Primary Sjogren’s Syndrome
  • Abstract Number: 1325
    Immune Responses to Peptides Containing Homocitrulline or Citrulline in the DR4-Transgenic Mouse Model of Rheumatoid Arthritis
  • Abstract Number: 2106
    Immune-Related Adverse Events in Cancer Patients Treated with Immune Check Point Inhibitors: A Single Center Experience
  • Abstract Number: 481
    Immunocompetent Cells Expressing Citrullinated Proteins in Joint Synovium of Osteoarthritis and Rheumatoid Arthritis
  • Abstract Number: 2415
    Immunogenicity and Persistence of a Prime-Boost Re-Vaccination Strategy for Pneumococcal Vaccines (13-Valent Pneumococcal Conjugate Vaccine + 23-Valent Pneumococcal Polysaccharide Vaccine) in Patients with Rheumatoid Arthritis: A Pilot Study
  • Abstract Number: 383
    Immunogenicity of 13 Valent Pneumococcal Vaccine in Children with Lupus: Single Center Experience in South Texas
  • Abstract Number: 2748
    Immunogenicity of Infliximab Among Patients with Behcet’s Syndrome: A Controlled Study
  • Abstract Number: 1940
    Immunologic Synovitis Score: A New Score for Synovial Membrane Characterization in Inflammatory and Non-Inflammatory Arthritis
  • Abstract Number: 2419
    Immunomodulatory Effects of Bone-Marrow Mesenchymal Stem Cells in Rheumatoid Arthitis: Influence of Disease Activity
  • Abstract Number: 676
    Immunosignature Autoantibody Profiles Provide Mechanistic Insight into Systemic Lupus Erythematosus and Differentiation from Symptomatically Overlapping Diseases
  • Abstract Number: 576
    Immunosignature-Based Diagnosis and Prediction of Therapeutic Response Enables Retrospective Patient Stratification in a Phase IIa Clinical Trial for VAY736 in Primary Sjögren’s Syndrome
  • Abstract Number: 116
    Immunotherapy-Induced Rheumatic Disease: How Prepared Are Rheumatologists to Address This Emerging Condition?
  • Abstract Number: 98
    Impact of a Lung Ultrasound Course for Rheumatology Specialist (IMPACT-2)
  • Abstract Number: 908
    Impact of a National Training Program on Primary Care Providers Utilization of Knee MRI
  • Abstract Number: 96
    Impact of a Student Led Rheumatology Interest Group on Medical Student Interest in Rheumatology
  • Abstract Number: 1155
    Impact of Adalimumab on Immunosuppressant Use in Patients with Active and Inactive Non-Infectious Intermediate, Posterior, or Pan-Uveitis in the Ongoing Open Label Study: Visual-III
  • Abstract Number: 1422
    Impact of Adalimumab on Prednisone Use in Patients with Rheumatoid Arthritis in a Real World Setting – Results from the Corrona Registry
  • Abstract Number: 1470
    Impact of Anti-Drug Antibody and Injection Site Reaction on Efficacy: 24-Week Results from a Phase III Study Comparing SB4 (etanercept biosimilar) with Reference Etanercept in Patients with Rheumatoid Arthritis
  • Abstract Number: 699
    Impact of Anti-RBP Antibodies on Disease Activity and Quality-of-Life in Immunosuppressant Naive Systemic Lupus Erythematosus
  • Abstract Number: 108
    Impact of Antiphospholipid Syndrome Ibook on Medical Students’ Improvement of Knowledge: An International Randomized Controlled Experimental Study
  • Abstract Number: 234
    Impact of Arthritis Among Populations with Chronic Health Conditions in Rural Counties of the United States – 2015
  • Abstract Number: 1222
    Impact of Bariatric Surgery on Bone Mineral Density : Observational Study of 110 Patients Followed up in a Specialised Centre for the Treatment of Obesity in France
  • Abstract Number: 1453
    Impact of Biological and Targeted Synthetic Dmards on Work in Patients with Chronic Inflammatory Arthritides : A Meta Analysis of Randomized Controlled Trials and Controlled Cohorts
  • Abstract Number: 2377
    Impact of Body Mass Index and Weight Loss on Incident Disability in Patients with Rheumatoid Arthritis
  • Abstract Number: 1162
    Impact of Bone Localization on the Prognostic of Langerhans Cell Histiocytosis: A Monocentric Retrospective Study
  • Abstract Number: 528
    Impact of Comorbidities on the Occurrence of Infections in Rheumatoid Arthritis Treated By Biologic Agents
  • Abstract Number: 743
    Impact of Detect on Right Heart Catheterization Referral and Results; Data from a Prospective, Unselected, Systemic Sclerosis Cohort
  • Abstract Number: 1129
    Impact of Diuretics on Urate Lowering Therapy in Patients with Gout: Analysis of an Inception Cohort
  • Abstract Number: 989
    Impact of DMARD Treatment on Risk of Repeat Cardiovascular Events Among Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis
  • Abstract Number: 1344
    Impact of Fibromyalgic RA on Composite Scores; Results from a Longitudinal Study of RA Patients Initiating Bdmard Therapy
  • Abstract Number: 1424
    Impact of Glucocorticoid Therapy on the Efficacy of SC Abatacept or Adalimumab in RA Patients with Inadequate Response to MTX: A Post Hoc Analysis of Data from a Head-to-Head Trial
  • Abstract Number: 2512
    Impact of Inflammatory Bowel Disease in Early Spondyloarthritis in a Prospective Longitudinal Cohort
  • Abstract Number: 1957
    Impact of Maternal Systemic Autoimmune Rheumatic Diseases on Neonatal Outcomes: A Population-Level Analysis
  • Abstract Number: 2246
    Impact of Patient Education Tool to Increase Cardiovascular Risk Konwledge, Attitudes, and Behaviors in Patietns with Rheumatoid Arthritis
  • Abstract Number: 1038
    Impact of Patient Support Program Utilization on Patient Activation Measure Scores Among Patients with Rheumatoid Arthritis
  • Abstract Number: 2677
    Impact of Rheumatologic Evaluation and Serologic Testing on Patients with Fibrotic Interstitial Lung Disease: A Single Center Retrospective Experience
  • Abstract Number: 2540
    Impact of Sleep on Measures of Disease Activity in Psoriatic Arthritis
  • Abstract Number: 428
    Impact of Smoking Cessstion Advise in Patients with  Rheumatoid Arthritis to Help Quit  Smoking
  • Abstract Number: 1383
    IMPACT of Smoking in the Expression of Periodontitis and Anticitrullinated Protein Antibodies in Rheumatoid Arthritis
  • Abstract Number: 1242
    Impact of Social Support and Illness Perception on the Transition of Pediatric SLE Patients to Adult Care
  • Abstract Number: 1053
    Impact of Step Therapy Protocols on North Carolina Rheumatologists’ Job Satisfaction and the Quality of Care Received By Their Patients with Rheumatoid Arthritis
  • Abstract Number: 133
    Impact of the Five Components of the Euroqol 5-Dimensions Instrument on Healthcare and Work-Loss Costs in Rheumatoid Arthritis: Observational Data from Southern Sweden
  • Abstract Number: 129
    Impact of the Multi-Biomarker Disease Activity Score Results on Whether Rheumatologists Changed Biologic Therapy for RA Patients
  • Abstract Number: 2392
    Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 1521
    Impact of Time Since Diagnosis, Age, and Number of Prior Non-Steroidal Anti-Inflammatory Drugs on 52-Week Clinical Response to Adalimumab in Patients with Ankylosing Spondylitis
  • Abstract Number: 1068
    Impact of TNF Antagonist Treatment on the Gut Microbiome In Vivo
  • Abstract Number: 2966
    Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials
  • Abstract Number: 1980
    Impact of Whole-Body Cryotherapy on Gene Expression of Peripheral Blood Cells in Patients with Fibromyalgia and Association with Patient-Reported Outcomes
  • Abstract Number: 1265
    Impaired Cardiac Function in Juvenile Mixed Connective Tissue Disease Compared with Controls
  • Abstract Number: 1911
    Impaired Control of Autoreactive T Cell Expansion Is Coupled with Type-1 Regulatory T Cell Deficiency in BALB/c ZAP70W163C Mutant Mice
  • Abstract Number: 200
    Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project
  • Abstract Number: 430
    Implementation of a Treat-to-Target Remission Strategy for Rheumatoid Arthritis in Australian Public and Private Rheumatology Clinics – Identification of Clinician and Patient Barriers
  • Abstract Number: 1338
    Important Role of CD11c+ Dendtritic Cells in Inflammatory Arthritis
  • Abstract Number: 187
    Improved Identification of Pseudogout in Electronic Medical Records By Adding Text String Searching to a Billing Code Algorithm
  • Abstract Number: 508
    Improved Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Failed Adalimumab or Placebo Treatment and Were Rescued with Baricitinib
  • Abstract Number: 595
    Improved Patient-Reported Outcomes in Psoriatic Arthritis Patients Treated with Abatacept: Results from a Phase III Trial
  • Abstract Number: 2029
    Improved Provider Awareness and Delivery of Zoster Vaccination in Patients with Rheumatoid Arthritis Contemplating Biologic Therapy: Need to Target Eligible Patients Prescribed for Vaccination Post-Clinic
  • Abstract Number: 2921
    Improved Survival Following Renal Transplantation in Waitlisted Patients with Systemic Lupus Erythematosus in the United States
  • Abstract Number: 1789
    Improved Survival with Transplantation in Granulomatosis with Polyangiitis in the United States: Data from the US Renal Data System
  • Abstract Number: 417
    Improvement in Overall Work Productivity Among Biologic-NaïVe Patients with Rheumatoid Arthritis Treated with Tocilizumab Subcutaneous Injection: A Prospective, Real World, Observational Study in Japan
  • Abstract Number: 376
    Improvement of Disease Activity in Patients with Colchicine-Resistant FMF, Hids/Mkd and TRAPS Assessed By Autoinflammatory Disease Activity Index (AIDAI): Results from a Randomized Phase III Trial
  • Abstract Number: 633
    Improvement of Joint Inflammation As Assessed By MRI and Power Doppler Ultrasound (PDUS) in an Open Label Study in Patients with Active Psoriatic Arthritis Treated with Secukinumab.
  • Abstract Number: 1515
    Improvements in Enthesitis Scores with Certolizumab Pegol Treatment in Males and Females with Active Axial Spondyloarthritis Are Maintained to Week 204
  • Abstract Number: 2480
    Improvements in Remission and Low Disease Activity Are Achieved with Ongoing Sarilumab Treatment, in Patients with Rheumatoid Arthritis in 2 Phase 3 Studies
  • Abstract Number: 1530
    Improvements in Sleep Problems and Pain in Patients with Active Ankylosing Spondylitis Treated with Intravenous Golimumab: 28-Week Results of the Phase III Trial
  • Abstract Number: 602
    Improvements in Work Productivity with up to 104 Weeks of Apremilast Monotherapy: Results from a Phase 3b, Randomized, Controlled Study in Biologic-NaïVe Subjects with Active Psoriatic Arthritis
  • Abstract Number: 2848
    Improving Gout Outcomes: The Randomized Evaluation of an Ambulatory Care Pharmacist-Led Intervention to Optimize Urate Lowering Pathways (RAmP-Up) Study
  • Abstract Number: 100
    Improving Internal Medicine Resident’s Knowledge through a Web-Based Musculoskeletal Educational Module
  • Abstract Number: 458
    Improving Knowledge of Rheumatoid Arthritis Clinical Trial Results Among Rheumatologists: Effect of an Online Educational Intervention
  • Abstract Number: 2994
    Improving Outcomes Using a Treat to Target Approach and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis
  • Abstract Number: 1081
    Improving Patient-Reported Outcomes Collection and Documentation for Patients with Rheumatoid Arthritis at Multilingual, Safety Net Hospital Rheumatology Clinic
  • Abstract Number: 2040
    Improving Quality of Care for Rheumatoid Arthritis Patients in an Underserved Area
  • Abstract Number: 1676
    Improving Sensitivity to Change of the Modified Rodnan Skin Score over Time
  • Abstract Number: 1989
    Improving Sleep in Fibromyalgia Patients Ameliorates Their Pain
  • Abstract Number: 721
    Improving the Quality of Care in Systemic Lupus Erythematosis (SLE) through Time-Structured, Information Technology-Enhanced, Quality Improvement Indicator-Driven Patient Management
  • Abstract Number: 1851
    Improving Walking Ability in Degenerative Lumbar Spinal Stenosis: A Randomized Trial Comparing 2 Self-Management Training Programs
  • Abstract Number: 2506
    In Ankylosing Spondylitis/Axial Spondyloarthritis Smoking Is Associated with a Dose Related Elevation in CRP, Worse Disease Activity and Worse Quality of Life over One Year
  • Abstract Number: 2686
    In Established Pulmonary Arterial Hypertension the Follow-up Cardiac Catheterization-Derived  Pulmonary Artery Systolic Pressure and Vascular Resistence May be Predicted By Echocardiography- a Longitudinal Study in Two Connective Tissue Disease Cohorts
  • Abstract Number: 1402
    In RA, Becoming Seronegative over the 1st Year of DMARD Treatment Does Not Improve Chances of Drug-Free Remission in the Long-Term
  • Abstract Number: 2452
    In Real-World Clinical Practice, Patients Switching from IV to SC Abatacept Maintain Clinical Efficacy after Switch
  • Abstract Number: 2400
    In Rheumatoid Arthritis: Vitamin-D Deficiency Is an Outcome and a Cause of Subclinical Renal Impairment
  • Abstract Number: 966
    In Search of Mechanisms Underlying Fibroblast-like Synoviocyte Cell-to-Cell Cargo Transfer
  • Abstract Number: 955
    In Vitro Effects of CR6086, a Potent ProstaglandinE2 Subtype 4 Receptor Antagonist, on Bone Erosive Pathways
  • Abstract Number: 52
    In Vivo Effect of Opticin Deficiency in a Surgically Induced Mouse Model of Osteoarthritis
  • Abstract Number: 1573
    In Vivo Phosphorylation of p38 in Monocytes Is Enhanced in Patients with Axial Spondyloarthritis (axSpA) at the Time of Diagnosis
  • Abstract Number: 1387
    In-Depth Temperature of Small and Large Joints Assessed By Microwave Radiometry As an Additional Biomarker in Rheumatoid Arthritis
  • Abstract Number: 2411
    In-Hospital Risk of Asthma in Patients with Rheumatoid Arthritis: A Cross-Sectional Nationwide Analysis
  • Abstract Number: 1478
    Inadequate Clinical Response to Sirukumab, an Anti-IL-6 Monoclonal Antibody, Can be Predicted after a Single Dose of Treatment in Patients with Rheumatoid Arthritis
  • Abstract Number: 997
    Incidence and Clinical Characteristics of Active Tuberculosis in a Cohort of Patients with Inflammatory Arthritis Treated with TNF-Inhibitors
  • Abstract Number: 1625
    Incidence and Outcomes of Venous Thromboembolism in Hospitalized Patients with Systemic Lupus Erythematosus: Results from Nationwide Inpatient Sample Database 2003-2011
  • Abstract Number: 2384
    Incidence and Predictors of Dyspnea on Exertion in a Prospective Cohort of Patients with Rheumatoid Arthritis
  • Abstract Number: 1777
    Incidence and Prevalence of Granulomatosis with Polyangiitis and Microscopic Polyangiitis in a Health Management Organization: A 15-Year Study
  • Abstract Number: 723
    Incidence and Variability of Cardiovascular Risk Factors in Female Lupus Patients: A 3-Year Follow-up
  • Abstract Number: 815
    Incidence in Large Vessel GCA in Northern Italy during a 11-Year Period
  • Abstract Number: 1483
    Incidence of Cancer in a Cohort of Patients with Primary Sjögren Syndrome
  • Abstract Number: 2459
    Incidence of Disease Worsening in Inflammatory Arthritis Patients on Long-Term Infliximab (Remicade®) Therapy
  • Abstract Number: 2520
    Incidence of Extra-Articular Manifestations in Psa and As Patients Treated with Golimumab in Canadian Real-World
  • Abstract Number: 813
    Incidence of Herpes Zoster in Patients with Polymyalgia Rheumatica: A Population-Based Cohort Study
  • Abstract Number: 142
    Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada
  • Abstract Number: 2391
    Incidence of Infections in Early Arthritis
  • Abstract Number: 545
    Incidence of Infusion Reactions to Intravenous Golimumab: Results from a Prospective, Real-World Community Registry
  • Abstract Number: 1364
    Incidence of Rheumatoid Arthritis in a Cohort of First Degree Relatives from the Studies of the Etiology of Rheumatoid Arthritis
  • Abstract Number: 16L
    Incidence of Thromboembolic Events in the Tofacitinib Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis and Ulcerative Colitis Development Programs
  • Abstract Number: 1429
    Incidence Rates of Adverse Events with Death As an Outcome during Abatacept Treatment in RA: Results from an Integrated Data Analysis from 16 Clinical Trials
  • Abstract Number: 1769
    Incidence, Predictors, and Outcome of Diffuse Alveolar Hemorrhage in Patients with MPO-ANCA Positive Microscopic Polyangiitis: A Multi-Center Retrospective Cohort Study
  • Abstract Number: 2945
    Incident Hand OA Is Strongly Associated with Reduced Peripheral Blood Leukocyte Telomere Length
  • Abstract Number: 102
    Incorporating Temporal Artery Ultrasound in a UK District General Hospital with No Prior Colour Doppler Sonography Service: An Encouraging Preliminary Analysis
  • Abstract Number: 1583
    Increase in Arginase Activity and Related Arginine Metabolites in Patients with Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA): Potential Mechanisms for Endothelial Dysfunction
  • Abstract Number: 993
    Increase in Prevalence of Psoriasis Arthritis over Time: Analysis of Claims Data from 65 Million People in Germany from 2009 to 2012
  • Abstract Number: 1611
    Increased Body Mass Index May Not be a Risk Factor for the Development of Lupus Nephritis
  • Abstract Number: 2406
    Increased Cartilage Damage in Metacarpophalangeal Joints of ACPA Positive Rheumatoid Arthritis (RA) Patients Using T2 Mapping in 3 Tesla Magnetresonance Imaging (MRI)
  • Abstract Number: 1846
    Increased CD38hiCD27+ Plasmablast Frequency in Remission Predicts Relapsing Disease in Granulomatosis with Polyangiitis Patients
  • Abstract Number: 2691
    Increased Circulating Cadherin-11 Levels in Patients with Systemic Sclerosis
  • Abstract Number: 2448
    Increased Cumulative Exposure to Tumor Necrosis Factor Inhibitors Reduces Radiographic Progression in US Veterans with Rheumatoid Arthritis in Real World Clinical Practice
  • Abstract Number: 1733
    Increased Differentiation Resistance of Regulatory T Cells to Endoplasmic Reticulum Stress in Systemic Lupus Erythematosus Patients
  • Abstract Number: 903
    Increased Expression of CCN4/WISP1 in Osteoarthritic Articular Cartilage Is Epigenetically Regulated and Disrupts Cartilage Homeostasis
  • Abstract Number: 2915
    Increased Expression of Malondialdehyde-Acetaldehyde Adducts (MAA) and Anti-Maa Antibody in Rheumatoid Arthritis-Interstitial Lung Disease
  • Abstract Number: 761
    Increased Expression of the TNF Superfamily Member LIGHT/TNFSF14 and Its Receptor (TNFRSF14) in Patients with Systemic Sclerosis
  • Abstract Number: 488
    Increased Expression of TNF-α and PAD-2 in Human Monocytes Following Treatment with Protein Modified with Malondialdehyde-Acetaldehyde (MAA) and Citrulline
  • Abstract Number: 18
    Increased Frequency of Nailfold Videocapillaroscopy Abnormalities in Primaryantiphospolipid (PAPS) Patients
  • Abstract Number: 1160
    Increased Incidence of Upper and Lower Gastrointestinal Events in Patients with Sarcoidosis: A Population-Based Cohort Study
  • Abstract Number: 1667
    Increased Levels of BAFF in SLE Patients Correlates with Neutrophil Activation and Autoantibody Production
  • Abstract Number: 766
    Increased Plasma Levels of Hsp90 Are Associated with More Severe Organ Involvement in Patients with Systemic Sclerosis
  • Abstract Number: 2527
    Increased Prevalence of Subclinical Atherosclerosis in Moderate-Severe Plaque Psoriasis Patients
  • Abstract Number: 1766
    Increased Renal Damage in Hypocomplementemic Patients with ANCA- Associated Vasculitis
  • Abstract Number: 2310
    Increased Risk of Extreme Obesity in Adults with History of Childhood Arthritis
  • Abstract Number: 1729
    Increased Serum Levels of Micro-RNA 30d and Micro-RNA 423-5p in 2 Independent Cohorts of Patients with Morphea
  • Abstract Number: 1071
    Increased Susceptibility of SLE-Prone Mice to Pulmonary Haemophilus Influenzae Infection Was Attributed to Dysfunctions of Innate Immune Responses
  • Abstract Number: 2644
    Increased Toll-like Receptor 7 Expression Promotes B Cell Abnormalities and Skewing of Cytokine and Autoantibody Profiles in SLE Patients
  • Abstract Number: 549
    Increases in Lipid Levels Following Sirukumab Treatment Are Associated with Suppression of Inflammation in Rheumatoid Arthritis: Results from Two Phase 3 Trials
  • Abstract Number: 1095
    Increasing Lipid Panel Monitoring in a Rheumatology Clinic
  • Abstract Number: 994
    Increasing Population Burden of Psoriatic Disease in Ontario, Canada – a Longitudinal Cohort Study
  • Abstract Number: 199
    Incremental Direct Medical Costs of Systemic Lupus Erythematosus Patients in the Years Preceding Diagnosis and the Impact of Sex: A General Population-Based Study
  • Abstract Number: 1293
    Indications for Cesarean Delivery in Systemic Lupus Erythematosus Pregnancies
  • Abstract Number: 1641
    Indications for Initial Renal Biopsy in Systemic Lupus Erythematosus: A Systematic Review of the Literature
  • Abstract Number: 2289
    Individualized Prediction of Early Remission on Medication in Juvenile Idiopathic Arthritis
  • Abstract Number: 2638
    Inducible cAMP Early Repressor Promotes Glycolysis By Inhibiting the Pyruvate Dehydrogenase Phosphatase Catalytic Subunit 2 in Th17 Cells
  • Abstract Number: 388
    Induction of Anti-Citrullinated Protein Antibodies By Peptidyl Arginine Deiminase Immunization: A New Model for the Development of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
  • Abstract Number: 1462
    Induction of Immune Tolerance through an Epitope-Specific Vaccine Induces Clinical Amelioration in Patients with Rheumatoid Arthritis
  • Abstract Number: 2603
    Induction of Lupus Nephritisin in Real Situation: Cyclophosphamide or Mycophenolate Mofetil?
  • Abstract Number: 1542
    Inequity in Biologic DMARD Prescription for Spa across the Globe:  Results from the Multi-Centre, Cross-Sectional, ASAS Comospa Study
  • Abstract Number: 2841
    Infection Is the Major Trigger of Adult Hemophagocytic Syndrome, an Orphan Systemic Hyperinflammatory, Life-Threatening Disease: Analysis in 147 Patients (GEAS-SEMI Registry)
  • Abstract Number: 2140
    Infections and Medications Associated with Onset of Myositis in Myovision, a National Myositis Patient Registry
  • Abstract Number: 2738
    Infectious Complications in Systemic Necrotizing Vasculitides: Pooled Analysis of Five Prospective, Randomized, Controlled Trials
  • Abstract Number: 591
    Inflammation on MRI of Spine and Sacroiliac Joints Is Highly Predictive of Structural Damage in Axial Spondyloarthritis: The 5 Years Data of the DESIR Cohort
  • Abstract Number: 2902
    Inflammatory Arthritis Due to Immune Checkpoint Inhibitors: A Persistent Problem Requiring Immunosuppression
  • Abstract Number: 1223
    Inflammatory Bowel Diseases and the Risks of Fracture and Low Mineral Density: Review of the Literature and Meta-Analysis of Observational Cohorts
  • Abstract Number: 1863
    Inflammatory Dietary Pattern and Risk of Developing Rheumatoid Arthritis in Women
  • Abstract Number: 588
    Inflammatory Lesions of the Sacroiliac Joints, but Not of the Spine, Are of High Utility for Recent Onset Axial Spondyloarthritis Recognition
  • Abstract Number: 2354
    Inflammatory Markers in Relation to Risk Factors for Cardiovascular Disease in the Pre-Symptomatic Phase of Rheumatoid Arthritis
  • Abstract Number: 2296
    Infliximab Use in JIA and Uveitis: Does Methotrexate Help or Hinder?
  • Abstract Number: 1935
    Influence of Adipokines on the Differentiation of Spongiosa-Derived Mesenchymal Stromal Cells from Osteoporosis and Osteoarthritis Patients
  • Abstract Number: 2525
    Influence of Cardiovascular Comorbidity on Achieving Therapeutic Goals: A Comparative Study between Recent-Onset Psoriatic Arthritis and Established Disease
  • Abstract Number: 208
    Influence of Depression on Healthcare Expenditures Among Adults with Spondylosis, Intervertebral Disc Disorders and Other Back Problems in the United States
  • Abstract Number: 1450
    Influence of Immunogenicity to the First Anti-TNF Therapy on Response to the Second Biologic Agent in RA Patients
  • Abstract Number: 2249
    Influence of Large-Joint Involvement on Patient-Physician Discordance in Global Assessment of Rheumatoid Arthritis Disease Activity Analyzed By Novel Joint Index
  • Abstract Number: 1315
    Influence of Rheumatoid Arthritis and Axial Spondyloarthritis on Pregnancy Complications, Pregnancy Outcome and Delivery Mode
  • Abstract Number: 1039
    Influences for Therapeutic Changes in Rheumatoid Arthritis Patients from the Veterans Affairs Rheumatology Arthritis Registry Who Have Moderate to High Disease Activity
  • Abstract Number: 1705
    Inhibition of EZH2 Stops Fibrosis and Improves Angiogenesis in Scleroderma
  • Abstract Number: 956
    Inhibition of Fucosylation in Endothelial Cells Reduces Rheumatoid Arthritis Angiogenesis
  • Abstract Number: 1714
    Inhibition of Hedgehog Acyltransferase Alleviates the Profibrotic Effects of Transforming Growth Factor β in Systemic Sclerosis
  • Abstract Number: 2564
    Inhibition of Neutrophil Elastase Protects Against Glomerulonephritis and Thrombosis in a Mouse Model of Lupus
  • Abstract Number: 2970
    Inhibition of Radiographic Progression in Psoriatic Arthritis By Adalimumab Independent of the Control of Clinical Disease Activity
  • Abstract Number: 2562
    Inhibition of Spleen Tyrosine Kinase Improves Renal Pathology and Reduces Lymphocyte Activation in the MRL/Lpr and NZB/NZW Murine Models of Systemic Lupus Erythematosus
  • Abstract Number: 1321
    Inhibition of the Mechanistic Target of Rapamycin Pathway and Glutaminolysis Facilitates the Expansion of Myeloid-Derived Suppressor Cells and Synergistically Ameliorates Arthritis in SKG Mice
  • Abstract Number: 1078
    Initial Combination Therapy Versus Step-up Therapy Is More Effective and Less Costly As a Treat to Target Strategy for RA: A Markov Model Based upon the Dutch Rheumatoid Arthritis Monitoring Registry Cohorts
  • Abstract Number: 1188
    Initial Estimates of Efficacy of Intra-Articular 2.5% Polyacrylamide Hydrogel for the Treatment of Knee Osteoarthritis: An Observational Proof-of-Concept Study
  • Abstract Number: 2091
    Initial Phase 2 Clinical Data of SEL-212 in Symptomatic Gout Patients: Monthly Dosing of a Pegylated Uricase (Pegsiticase) with Svp-Rapamycin Enables Sustained Reduction of Serum Uric Acid Levels By Mitigating Formation of Anti-Drug Antibodies
  • Abstract Number: 1141
    Initial Results of a Clinical Study to Determine Whether a Tolerizing Regimen of Pegloticase Can Increase the Frequency of Subjects Having Sustained Lowering of Serum Urate
  • Abstract Number: 2252
    Initial Validation of Patient-Reported Outcomes Measurement Information System (PROMIS®) in Children with Juvenile Myositis
  • Abstract Number: 1144
    Initiating Colchicine and Urate-Lowering Therapy Reduces Baseline Inflammation, and Improves Vascular Endothelial but Not Smooth Muscle Function in Gout Subjects: Resistance to Endothelial Improvement Among Patients with Cardiovascular Comorbidities
  • Abstract Number: 468
    Initiation of Biologic Disease Modifying Antirheumatic Drug Therapy and Associated Changes in Disease Activity Measures in Routine Clinical Practice: Findings from a Large Contemporaneous Real World Cohort
  • Abstract Number: 862
    iNKT Mediated Immunoregulatory Feedback Control Development of Autoimmune Arthritis in Mice
  • Abstract Number: 655
    Innate Lymphoid Cells – New Players in Psoriatic Arthritis
  • Abstract Number: 1797
    Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center
  • Abstract Number: 1725
    Insulin-like Growth Factor Binding Protein-4 Exerts Anti-Fibrotic Effects and Its Levels Are Reduced in SSc-Associated Lung Fibrosis
  • Abstract Number: 619
    Integrated Efficacy Analysis of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients with Active Psoriatic Arthritis
  • Abstract Number: 628
    Integrated Efficacy Results from Two Phase 3 Trials of Ixekizumab for the Treatment of Psoriatic Arthritis
  • Abstract Number: 2806
    Integrated Longitudinal Analysis Increases Precision and Reduces Bias: A Comparative 5-Year Analysis in the DESIR Cohort
  • Abstract Number: 2472
    Integrated Phase 3 Safety Results of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis
  • Abstract Number: 616
    Integrated Safety Summary of Tofacitinib in Psoriatic Arthritis Clinical Studies
  • Abstract Number: 770
    Integrating Analysis of Skin RNA in Situ Hybridization Using Rnascope and Whole Skin Gene Expression in Systemic Sclerosis Skin to Localize Key Pathogenic Drivers of Skin Fibrosis
  • Abstract Number: 351
    Integration of Electronically Captured Patient-Reported Outcomes in a Pediatric Rheumatology Clinic Visit
  • Abstract Number: 166
    Integrative Systems Biology Approach Identifies Key Transcription Factors and Novel Rheumatoid Arthritis (RA) and Individualized Therapeutic Targets
  • Abstract Number: 203
    Intensive Care Unit Admissions Among Patients with Rheumatic Diseases at a Tertiary Care Center
  • Abstract Number: 2552
    Inter-Connections between Fatigue, Pain and Patient Global Assessement in Patients with Active Spondyloarthritis Followed in the Daily Clinic
  • Abstract Number: 1913
    Inter-Omic Analysis Reveals Functional Relationship between Diverse Gut Microbiota and Dysregulated Host Immune Response in HLA-B27-Mediated Experimental Spondyloarthritis
  • Abstract Number: 1463
    Interaction between Methotrexate and BAFF for Preventing Immunization Against TNF-α Inhibitors By Increasing Adenosine and Regulatory B-Cell Subsets
  • Abstract Number: 1655
    Interferon b Blockade Rescues Human BM-MSC Osteoblastogenesis Defects in Systemic Lupus Erythematosus
  • Abstract Number: 1728
    Interferon Gamma (IFN-γ) Subpopulations in Skin Homing T Cells of Localized Scleroderma
  • Abstract Number: 1369
    Interferon Gamma Signature Genes and CXCL10 As New Biomarkers in Early Stage of Rheumatoid Arthritis
  • Abstract Number: 2927
    Interferon Regulatory Factor (IRF) 7 in Type I IFN Signaling Represents As a Key Upstream Regulator in Early Diffuse SSc Patients and Plays Critical Role in Pathogenesis of Fibrosis
  • Abstract Number: 1658
    Interferon Related Soluble Mediator Concentrations Significantly Correlate with Disease Activity in SLE Patients with Active Interferon Pathways
  • Abstract Number: 754
    Interferon Siganture in Systemic Sclerosis Lung Microvascular Endothelial Cells
  • Abstract Number: 2349
    Interferon Signature in Childhood Rheumatic Diseases
  • Abstract Number: 831
    Interferon-Alpha Disrupts Tolerance in a Mouse Model of B Cell Anergy
  • Abstract Number: 866
    Interferon-Alpha Overexpression Triggers an Expansion of Highly Suppressive Regulatory T Lymphocytes Protecting Against Experimental Arthritis
  • Abstract Number: 2813
    Interferon-Induced APOL1 over-Expression Causes Autophagic Dysfunction and Mitochondrial Stress in Risk Variant-Carrying Endothelial Cells
  • Abstract Number: 2814
    Interferon-β Production By B Cells Promotes B Cell Survival and Is Strongly Associated with Active Disease in African Americans with SLE
  • Abstract Number: 1930
    Interleukin 1β Decreases Capacity for Repair Human Cartilage Lesions By Mesenchymal Stromal Cells on Collagen/Proteoglycan Scaffolds
  • Abstract Number: 367
    Interleukin-1  Receptor Antagonist Is a Potential Treatment for Undifferentiated Autoinflammatory Syndromes
  • Abstract Number: 1793
    Interleukin-17 Is Not a Determinant for the Pro- or Anti-Inflammatory Character of Interleukin-22 in Experimental Arthritis
  • Abstract Number: 2574
    Interleukin-33 Ameliorates Murine Lupus Via Induction of Regulatory T Cells and M2 Macrophage Polarisation
  • Abstract Number: 1152
    Interleukin-37 As an Independent Disease Activity Marker of Adult-Onset Still’s Disease
  • Abstract Number: 634
    International League of Associations for Rheumatology. Systematic Review of the Literature to Inform Treatment Recommendations for Psoriatic Arthritis in Resource-Poor Countries
  • Abstract Number: 1756
    Interstitial Lung Disease in ANCA Associated Vasculitis: A Distinct or an Incomplete Subset in ANCA Vasculitis Patients?
  • Abstract Number: 1486
    Interstitial Lung Disease in Primary Sjögren’s Syndrome : Clinical Presentation, Serological Biomarkers and Long Term Outcome
  • Abstract Number: 2114
    Interstitial Pneumonia with Autoimmune Features (IPAF): Are There Definable Subsets?
  • Abstract Number: 1198
    Intra-Articular Hyaluronic Acid Delay to Total Knee Arthroplasty By Number of Injection Courses Received: Analysis of an Administrative Database
  • Abstract Number: 599
    Intravenous Golimumab in Adult Patients with Active Psoriatic Arthritis: Efficacy and Safety through Week 24
  • Abstract Number: 2166
    Intravenous Immunoglobulins in Idiopathic Inflammatory Myopathies: Efficacy and Predictive Factors for Clinical Response
  • Abstract Number: 177
    Intronic Variants of the B-Cell Proliferator RASGRP3 Affect Its Expression, and Might Contribute to Lupus Risk
  • Abstract Number: 1066
    Invention and Phenotypic Evaluation of Human IgG4-Knock-in Mice
  • Abstract Number: 2174
    Investigating Exercise- and Crossfit-Induced Rhabdomyolysis: Data from a Community Healthcare System
  • Abstract Number: 1097
    Investigating Opportunities for Cost Conscious Care: A Review of Physician Practice in Ordering Anti-Nuclear Antibody Testing at an Academic Community Hospital
  • Abstract Number: 652
    Investigating the Role of Mechanical Stress in Spondyloarthritis Pathogenesis
  • Abstract Number: 1269
    Investigating Time Trends in Incident Pediatric Lupus across Ethnic Groups in Toronto, Canada—a Large, Multiethnic Metropolitan Area
  • Abstract Number: 1017
    Investigation of Differential Methylation As a Potential Biomarker of Methotrexate Response in Patients with Rheumatoid Arthritis
  • Abstract Number: 1455
    Investigation of Poor Prognostic Factors Among Rheumatoid Arthritis Patients in Turkbio Registry
  • Abstract Number: 2211
    Investigation of Self-Reported Painful Joint Count As an Outcome Measure in Hand Osteoarthritis
  • Abstract Number: 1138
    Investigation on Allele Frequency of Rs3117583 and Rs9263726 in Patients with Hyperuricemia or Gout
  • Abstract Number: 2228
    Involvement of Receptor Tyrosine Kinase a  Signaling in Rhumatoid Arthritis Using Trka/C Knock-in Mice: A Multimodal Approach
  • Abstract Number: 1742
    Involvement of T Helper 17 Cells in Inflammatory Arthritis Depends on the Host Intestinal Microbiota
  • Abstract Number: 1833
    iRhom2 Deficiency Protects Fcgr2b-/- Lupus-Prone Mice from Kidney Damage By Modulating ADAM17-Dependent Shedding of TNF-α and EGFR Ligand
  • Abstract Number: 51
    Irisin Ameliorates Infrapatellar Adiposity in Knee Osteoarthritis Pathogenesis By Orchestrating Adipokine Signaling
  • Abstract Number: 2511
    Irritable Bowel Syndrome and Its Impact on Patient-Reported Outcomes in Axial Spondyloarthritis: Is It an Overlooked Comorbidity?
  • Abstract Number: 2181
    Is a Decrease in MRI-Defined Inflammation Associated with a Decrease in Pain in Patients with Hand Osteoarthritis? a Two-Year Follow-up Study
  • Abstract Number: 2991
    Is a Growing Waistline over 8 Years Associated with Incident Functional Limitation and Low Health-Related Quality of Life in Knee Osteoarthritis?
  • Abstract Number: 1356
    Is ACPA-Positive RA Still a More Severe Disease Than ACPA-Negative RA? a Longitudinal Cohort Study in RA-Patients Treated from 2000 Onwards
  • Abstract Number: 1340
    Is Depression in Patients with Rheumatoid Arthritis Associated with Disease Activity? Comparative Study between Germany and Brazil
  • Abstract Number: 629
    Is Earlier Golimumab Treatment Initiation in Psa and As Patients Associated with Improved Outcomes?
  • Abstract Number: 574
    Is Elastography a New Tool to Differentiate Sjögren Syndrome to Sicca Syndrome?: Results of the Elsa (elastography of salivary glands) Study
  • Abstract Number: 2853
    Is Frailty Associated with Adverse Events after Total Joint Arthroplasty?
  • Abstract Number: 980
    Is Intra-Articular Injection of Synvisc Associated with a Delay to Knee Arthroplasty in Knee OA Patients?
  • Abstract Number: 1438
    Is It Necessary to Weight By Weight the Dosage of MTX in RA Patients? Results from Obsevational Analysis of Baseline Data of a Phase III Trial
  • Abstract Number: 1353
    Is Joint Damage Due to Secondary Osteoarthritis (OA) Clinically As Important As Inflammation in Contemporary Management of Rheumatoid Arthritis (RA)?
  • Abstract Number: 492
    Is Leukotoxin_A Produced By Aggregatibacter Actynomycetemcomitans Important for Initiating Autoimmune Responses Underlying Rheumatoid Arthritis?
  • Abstract Number: 158
    Is Lu Eight-Brocades Exercise Beneficial for Patients with Fibromyalgia?
  • Abstract Number: 2990
    Is Risk of Retinopathy Among Hydroxychloroquine Users of SLE Patients Accurate? a Simulation Study Accounting for Competing Risk of Death
  • Abstract Number: 1512
    Is Sacroiliac Imaging the All-Decisive Factor in the Diagnosis of Early Axial Spondyloarthritis? Data from the Spondyloarthritis Caught Early (SPACE) Cohort
  • Abstract Number: 2718
    Is Smoking Important in Adult IgA Vasculitis?
  • Abstract Number: 2938
    Is Synovial Hypertrophy without Doppler Activity in Rheumatoid Arthritis Joints Sensitive to Change ? – Results of a Longitudinal Ultrasound Study
  • Abstract Number: 191
    Is the Nature of Rheumatology Practice Changing?  Damage and Distress Contribute a Greater Proportion to Decision-Making Than Inflammation in Contemporary Care
  • Abstract Number: 569
    Is the Oral Microbiome Involved in the Pathogenesis of Sjogren’s Syndrome?
  • Abstract Number: 640
    Is There a Relationship between Spondyloarthritis and Periodontitis? a Case-Control Study
  • Abstract Number: 1491
    Is There a Seasonal Effect on Fatigue, Pain, and Dryness in Primary Sjögren’s Syndrome?  Data from the Prospective Assess Cohort and  from 3 Randomized Controlled Trials
  • Abstract Number: 2735
    Is There an Association between Adult IgA Vasculitis and Cancer?
  • Abstract Number: 542
    Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry?
  • Abstract Number: 668
    Is Uric Acid Level a Predictor of Long-Term Renal Outcome in Lupus Nephritis?
  • Abstract Number: 1569
    Isotretinoin Induced Seronegative Spondyloarthropathy: Magnetic Resonance Imaging As Diagnostic and Prognostic Biomarker
  • Abstract Number: 605
    Ixekizumab Exhibits a Favorable Safety Profile during 24 Weeks of Treatment in Subjects with Active Psoriatic Arthritis: Integrated Safety Analysis of Two Randomized, Placebo Controlled, Phase III Clinical Trials
  • Abstract Number: 597
    Ixekizumab Improves Patient-Reported Outcomes through 52 Weeks in Patients with Active Psoriatic Arthritis and Previous Inadequate Response to Tumor Necrosis Factor-Inhibitors
  • Abstract Number: 624
    Ixekizumab Provides Sustained Improvement in Signs and Symptoms in Patients with Active Psoriatic Arthritis: Two Year Results from a Phase 3 Trial
Jump to:  View All • a b c d e f g h [i] j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences